Level D· Scientific groundwork from lab and animal studiesLaboratory StudyEurope PMC

Thank you for the privilege

Kaya D., Doral M., Nyland J., Toprak U., Turhan E., Donmez G.

Laboratory Study with a reported sample of 70 on Osteoarthritis, Cartilage Damage, Meniscus Injury, Tendon Injury, published in Muscles Ligaments Tendons J (2012) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Muscles Ligaments Tendons J (2012)
Reported sample size
70
Source database
Europe PMC
PMCID
PMC3671359

Abstract (original English)

Thank you for the privilege to serve as the EFOST President. I am deeply humbled for having been selected to serve as the new President of EFOST: this is not for the work that I have undertaken, but for what others around me have done. I hope that my past duties as President of BOSTAA, and as president of the Sports and Exercise Medicine of the Royal Society of Medicine will help me in performing these my new duties. It all started in 1992, and the EFOST is now just leaving its adolescent phase, with all its teenager problems. There is truth in Newton’s quote about standing on the shoulders of giants. Francois, you and the other leaders at EFOST have generated the momentum to keep moving EFOST forward, and the wisdom to keep it moving in the right direction. We all benefited from your contributions, dedication and volunteerism. To step into this role feels a little like steering a train. EFOST operates under a strategic plan which sets our direction and controls how the changing succession of leaders navigates. This plan is critical to helping us maintain focus, direction, and purpose. It is crucial that we focus on our strategic direction. However, we must continue to monitor the environment around us. We must recognize the changing influences so that we can respond appropriately. Europe is in a state of flux, with great challenges, both scientifically and economically. Strate

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research